MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00439-014-1498-1

Медицинская библиотека · Human genetics · 2014

De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum.

Kuechler Alma, Willemsen Marjolein H, Albrecht Beate, Bacino Carlos A, Bartholomew Dennis W, van Bokhoven Hans, van den Boogaard Marie Jose H, Bramswig Nuria, Büttner Christian, Cremer Kirsten, Czeschik Johanna Christina, Engels Hartmut, van Gassen Koen, Graf Elisabeth, van Haelst Mieke, He Weimin, Hogue Jacob S, Kempers Marlies, Koolen David, Monroe Glen, de Munnik Sonja, Pastore Matthew, Reis André, Reuter Miriam S, Tegay David H, Veltman Joris, Visser Gepke, van Hasselt Peter, Smeets Eric E J, Vissers Lisenka, Wieland Thomas, Wissink Willemijn, Yntema Helger, Zink Alexander Michael, Strom Tim M, Lüdecke Hermann-Josef, Kleefstra Tjitske, Wieczorek Dagmar

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Recently, de novo heterozygous loss-of-function mutations in beta-catenin (CTNNB1) were described for the first time in four individuals with intellectual disability (ID), microcephaly, limited speech and (progressive) spasticity, and functional consequences of CTNNB1 deficiency were characterized in a mouse model. Beta-catenin is a key downstream component of the canonical Wnt signaling pathway. Somatic gain-of-function mutations have already been found in various tumor types, whereas germline loss-of-function mutations in animal models have been shown to influence neuronal development and maturation. We report on 16 additional individuals from 15 families in whom we newly identified de novo loss-of-function CTNNB1 mutations (six nonsense, five frameshift, one missense, two splice mutation, and one whole gene deletion). All patients have ID, motor delay and speech impairment (both mostly severe) and abnormal muscle tone (truncal hypotonia and distal hypertonia/spasticity). The craniofacial phenotype comprised microcephaly (typically -2 to -4 SD) in 12 of 16 and some overlapping facial features in all individuals (broad nasal tip, small alae nasi, long and/or flat philtrum, thin upper lip vermillion). With this detailed phenotypic characterization of 16 additional individuals, we expand and further establish the clinical and mutational spectrum of inactivating CTNNB1 mutations and thereby clinically delineate this new CTNNB1 haploinsufficiency syndrome.

Для цитирования: Kuechler Alma, Willemsen Marjolein H, Albrecht Beate, Bacino Carlos A, Bartholomew Dennis W, van Bokhoven Hans, van den Boogaard Marie Jose H, Bramswig Nuria, Büttner Christian, Cremer Kirsten, Czeschik Johanna Christina, Engels Hartmut, van Gassen Koen, Graf Elisabeth, van Haelst Mieke, He Weimin, Hogue Jacob S, Kempers Marlies, Koolen David, Monroe Glen, de Munnik Sonja, Pastore Matthew, Reis André, Reuter Miriam S, Tegay David H, Veltman Joris, Visser Gepke, van Hasselt Peter, Smeets Eric E J, Vissers Lisenka, Wieland Thomas, Wissink Willemijn, Yntema Helger, Zink Alexander Michael, Strom Tim M, Lüdecke Hermann-Josef, Kleefstra Tjitske, Wieczorek Dagmar. De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum.. Human genetics. 2014. DOI: 10.1007/s00439-014-1498-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.